Your browser doesn't support javascript.
loading
Rovalpituzumab Tesirine as a Maintenance Therapy After First-Line Platinum-Based Chemotherapy in Patients With Extensive-Stage-SCLC: Results From the Phase 3 MERU Study.
Johnson, Melissa L; Zvirbule, Zanete; Laktionov, Konstantin; Helland, Aslaug; Cho, Byoung Chul; Gutierrez, Vanesa; Colinet, Benoît; Lena, Herve; Wolf, Martin; Gottfried, Maya; Okamoto, Isamu; van der Leest, Cor; Rich, Patricia; Hung, Jen-Yu; Appenzeller, Christina; Sun, Zhaowen; Maag, David; Luo, Yan; Nickner, Caroline; Vajikova, Alena; Komarnitsky, Philip; Bar, Jair.
Afiliação
  • Johnson ML; Department of Medical Oncology, Sarah Cannon Cancer Research Institute/Tennessee Oncology, PLLC, Nashville, Tennessee. Electronic address: Melissa.Johnson@sarahcannon.com.
  • Zvirbule Z; Latvian Oncology Centre, Riga East University Hospital, Riga, Latvia.
  • Laktionov K; Federal State Budgetary Institution "N.N.Blokhin National Medical Research Center of Oncology" of the Ministry of Health of the Russian Federation (N.N. Blokhin NMRCO), Moscow, Russia.
  • Helland A; Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, University of Oslo, Oslo, Norway.
  • Cho BC; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.
  • Gutierrez V; Department of Medical Oncology, Hospital Regional Universitario de Málaga, Málaga, Spain.
  • Colinet B; Department of Pneumology, Grand Hôpital de Charleroi, Charleroi, Belgium.
  • Lena H; Centre Hospitalier Universitaire, Rennes, Hospital de Pontchaillou, France; INSERM U 1242, Université Rennes 1, Rennes, France.
  • Wolf M; Department of Hematology and Oncology, Klinikum Kassel Hospital, Kassel, Germany.
  • Gottfried M; Department of Oncology, Meir Medical Center, Kfar Saba, Israel.
  • Okamoto I; Department of Medical Oncology, Kyushu University Hospital, Fukuoka, Japan.
  • van der Leest C; Department of Pulmonology, Amphia Ziekenhuis, Breda, the Netherlands.
  • Rich P; Department of Medical Oncology, Cancer Treatment Centers of America, Newnan, Georgia.
  • Hung JY; Division of Pulmonary and Critical Care Medicine, Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan.
  • Appenzeller C; Division of Oncology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
  • Sun Z; AbbVie, Inc, North Chicago, Illinois.
  • Maag D; AbbVie, Inc, North Chicago, Illinois.
  • Luo Y; AbbVie, Inc, North Chicago, Illinois.
  • Nickner C; AbbVie, Inc, North Chicago, Illinois.
  • Vajikova A; AbbVie, Inc, North Chicago, Illinois.
  • Komarnitsky P; AbbVie, Inc, North Chicago, Illinois.
  • Bar J; Department of Oncology, Sheba Medical Center, Ramat Gan, Israel; Sackler Medical School, Tel-Aviv University, Tel-Aviv, Israel.
J Thorac Oncol ; 16(9): 1570-1581, 2021 09.
Article em En | MEDLINE | ID: mdl-33823285
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoconjugados / Neoplasias Pulmonares Tipo de estudo: Clinical_trials Limite: Humans / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoconjugados / Neoplasias Pulmonares Tipo de estudo: Clinical_trials Limite: Humans / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article